Dr Richard Hopkins Appointed as CEO of PharmAust
170301_Dr Richard Hopkins Appointed as CEO of PharmAust
170301_Dr Richard Hopkins Appointed as CEO of PharmAust
170131_Appendix 4C – Quarterly Report & Company Update for the period ended 31 December 2016
170130_PHARMAUST RECEIVES $406K R&D REBATE FROM ATO
170228_Appendix 4D Half-Year Report for the period ended 31 December 2016
160229_Appendix 4D & Half Yearly Report and Accounts
161230_PHARMAUST RAISES A FURTHER $1.56M
161208_COMPLETION OF RIGHTS ISSUE AND NOTICE OF SHORTFALL
161205_RIGHTS ISSUE – EXTENSION OF CLOSING DATE